Efficacy of Hyperthermia in Treatment of Recurrent Metastatic Breast Cancer After Long-Term Chemotherapy: A Report of 2 Cases

Hirozumi Sawai; Masaaki Kurimoto; Yuka Suzuki; Yoshimi Yamaguchi; Akemi Murata; Enami Suganuma; Kazuya Yamamoto; Hiromasa Kuzuya; Shuhei Ueno; Shuji Koide; Hajime Koide; Atsushi Kamiya

doi:10.12659/AJCR.926647

03 November 2020 : Case report Japan

Efficacy of Hyperthermia in Treatment of Recurrent Metastatic Breast Cancer After Long-Term Chemotherapy: A Report of 2 Cases

Unusual clinical course, Unusual setting of medical care

Hirozumi Sawai^1ABCDEF*, Masaaki Kurimoto^1ABCD, Yuka Suzuki^2BCD, Yoshimi Yamaguchi^2BCD, Akemi Murata^2BCD, Enami Suganuma^2BCD, Kazuya Yamamoto^2ABCD, Hiromasa Kuzuya^1BCDF, Shuhei Ueno^1BCDF, Shuji Koide^1ABCF, Hajime Koide^1BCDF, Atsushi Kamiya^1ABCE

DOI: 10.12659/AJCR.926647

Am J Case Rep 2020; 21:e926647

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Figure 4. Changes in newly developed liver metastasis on E-CT imaging. Twenty-five years after surgery, E-CT (A) revealed newly developed liver metastasis (white arrowhead). E-CT after administration of eribulin mesylate for 8 months showed no reduction in liver metastasis (B). E-CT images after receiving 30 cycles of RF hyperthermia (C) (white arrowheads) showed liver metastasis that gradually reduced.

Back to the Article

Efficacy of Hyperthermia in Treatment of Recurrent Metastatic Breast Cancer After Long-Term Chemotherapy: A Report of 2 Cases

Your Privacy